TN2010000418A1 - Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts - Google Patents

Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts

Info

Publication number
TN2010000418A1
TN2010000418A1 TNP2010000418A TN2010000418A TN2010000418A1 TN 2010000418 A1 TN2010000418 A1 TN 2010000418A1 TN P2010000418 A TNP2010000418 A TN P2010000418A TN 2010000418 A TN2010000418 A TN 2010000418A TN 2010000418 A1 TN2010000418 A1 TN 2010000418A1
Authority
TN
Tunisia
Prior art keywords
benzimidazol
methylpiperazin
quinolin
fluoro
amino
Prior art date
Application number
TNP2010000418A
Other languages
French (fr)
Inventor
Danielle Giron
Walter Hammerschmidt
Philippe Piechon
Johanne Polasek
Andreas Shreiner
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/053222 external-priority patent/WO2009115562A2/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2010000418A1 publication Critical patent/TN2010000418A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Crystalline forms or polymorphs of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts, as well as to methods of making the same, pharmaceutical compositions comprising the same and methods of treatment using the same.
TNP2010000418A 2009-03-18 2010-09-08 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts TN2010000418A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/053222 WO2009115562A2 (en) 2008-03-19 2009-03-18 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts

Publications (1)

Publication Number Publication Date
TN2010000418A1 true TN2010000418A1 (en) 2011-12-29

Family

ID=55024541

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000418A TN2010000418A1 (en) 2009-03-18 2010-09-08 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts

Country Status (1)

Country Link
TN (1) TN2010000418A1 (en)

Similar Documents

Publication Publication Date Title
PH12012502568A1 (en) Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
MX2012002875A (en) 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof.
IL223350A0 (en) Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
MX2021001169A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
MY164274A (en) Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
MY150518A (en) Substituted gamma lactams as therapeutic agents
MX2012002179A (en) Heterocyclic oxime compounds.
MX2011009847A (en) Anthelmintic agents and their use.
UA115357C2 (en) Pyridin-4-yl derivatives
PH12014500079A1 (en) 6-substituted phenoxychroman carboxylic acid derivatives
MX339619B (en) Formulations, salts and polymorphs of transnorsertraline and uses thereof.
IL214408A0 (en) Derivatives of 6-(6-substituted-triazolopyidazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
SMT201300112B (en) Citrate salt of 9E-15- (2-pyrrolidin-1-yl-ethoxy) -7,12,25-triossa-19,21,24-triaza-tetracycloÄ18.3.1.1 (2,5) .1 (14, 18) Üesacos a-1 (24), 2,4,9,14,16,18 (26), 20,22-nonaene
EP2862573A4 (en) Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
TN2010000418A1 (en) Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
MX351994B (en) Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5 -carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl]-amide.
TH0901001214A (en) crystalline form and two solvated forms of salt. 4-amino-5-fluoro-3-[5-(4-methylpiperacin-1-yl)-1H-benzimidazol-2-yl ]Quinolin-2(1H)-one lactic acid
IL222642A0 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
MX2011012329A (en) Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmet hyl)pyridine and their therapeutical uses.
TN2010000488A1 (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
CL2009001927A1 (en) Compounds derived from 4- (2-oxo-1,2-dihydro-4-pyridinyl) -3-piperidine carboxamide; pharmaceutical composition; and use in the treatment or prophylaxis of diseases such as hypertension, congestive heart failure, pulmonary hypertension, atherosclerosis, among others.
CL2012002798A1 (en) Pharmaceutical salt of 1-cyclopropyl-8-methyl-7- [5-methyl-6- (methylamino) -3-pyridinyl] -4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; selected from citrate salt, hemifumarate, maleate, l-tartrate, mesylate, hydrochloride, potassium and sodium; pharmaceutical composition; and use to treat or prevent bacterial infections.
MX2013004650A (en) Polymorphs of febuxostat.